ACUTE MONOCYTIC LEUKEMIA
Clinical trials for ACUTE MONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) who have run out of standard treatments. The main goals are to find a safe dose and check for side effects. About 105 participant…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
Promising new combo targets hard-to-treat leukemia
Disease control Recruiting nowThis study tests a new combination of drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML). The treatment uses venetoclax, a targeted drug, along with chemotherapy drugs cladribine, cytarabine, and azacitidine. The goal is to see if this combinati…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
New leukemia combo shows promise in early trial
Disease control Recruiting nowThis study compares a new treatment (venetoclax plus CACAG) to standard chemotherapy for people with acute monocytic leukemia. About 204 participants aged 14-60 will be randomly assigned to one of the two groups. The main goal is to see if the new combination leads to more comple…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for leukemia patients too frail for chemo?
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) for people newly diagnosed with a specific type of leukemia called acute monocytic leukemia who are not healthy enough for standard intensive chemotherapy. The goal is to see if this drug combo…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC